Daptomycin: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "4 mg" to "4mg") |
Neil.m.young (talk | contribs) (Text replacement - "6 mg" to "6mg") |
||
Line 8: | Line 8: | ||
**4mg/kg q24h x7-14 days | **4mg/kg q24h x7-14 days | ||
*Staph bacteremia: | *Staph bacteremia: | ||
** | **6mg/kg IV q24h x2-6 wks | ||
*Renal dosing | *Renal dosing | ||
**CrCl <30, give q48h | **CrCl <30, give q48h |
Revision as of 08:33, 19 July 2016
General
- Type: bacterial antibiotic
- Dosage Forms: IV
- Common Trade Names: Cubicin
Adult Dosing
- Complicated bacterial skin infections:
- 4mg/kg q24h x7-14 days
- Staph bacteremia:
- 6mg/kg IV q24h x2-6 wks
- Renal dosing
- CrCl <30, give q48h
- HD: give dose after dialysis, no supplement
- PD: no supplement
Pediatric Dosing
- Unavailable
Special Populations
- Pregnancy Rating: B
- Lactation: Infant risk cannot be ruled out
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
- CK > 10x upper limit normal
- CK > 10x upper limit normal with myopathy
- caution in elderly
- caution in recent antibiotic-associated colitis
Adverse Reactions
Serious
- C. difficile diarrhea
- Superinfection
- Eosinophilic pneumonia
- Anaphylaxis
- Drug rash
- Thrombocytopenia
- Myopathy
- Rhabdomyolysis
- Peripheral neuropathy
Common
- Insomnia
- Pharyngeal pain
- Elevated CK
- Chest pain
- Edema
- Abdominal pain
- Pruritis
- Headache
- Diarrhea
Pharmacology
- Half-life: 8-9 h
- Metabolism: unknown
- Excretion: Urine 78%
- Mechanism of Action: Bactericidal, binds/depolarizes bacterial membranes
Antibiotic Sensitivities[1]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
See Also
Source
- ↑ Sanford Guide to Antimicrobial Therapy 2014